HCM - Ticker AI Digest

HUTCHMED China Ltd
223.75 | Today 0.79%
TradingFloor AI GO VIP Login

Digested News

Today's Catalysts (HCM) 0
No same-day market news for HCM on 2026-04-15.
AI 0
No items for this category on selected date.
Acquisitions 0
No items for this category on selected date.
Agreement 0
No items for this category on selected date.
Approvals 0
No items for this category on selected date.
Authorisation 0
No items for this category on selected date.
Awards 1
HCM 07:31
HUTCHMED China Ltd
Vesting of awards under Long Term Incentive Plan
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
**Summary**
HUTCHMED (China) Limited announced the vesting of non-performance-based awards under its Long Term Incentive Plan (LTIP) on March 13, 2026. Dr. Weiguo Su, the companys Executive Director, Chief Executive Officer, and Chief Scientific Officer, received 19,913 ordinary shares as part of this vesting. The awards were initially granted on March 13, 2024. This notification complies with the UK Market Abuse Regulation and includes details about the transaction, the issuer, and the person discharging managerial responsibilities.
HUTCHMED is an innovative biopharmaceutical company focused on developing and commercializing targeted therapies and immunotherapies for cancer and immunological diseases. The company has successfully brought three medicines to market in China, with one also approved globally in regions including the US, Europe, and Japan. Contact information for investor and media enquiries, as well as details about the companys brokers, is provided. The announcement was released via RNS, the news service of the London Stock Exchange, on March 16, 2026.
BTC 0
No items for this category on selected date.
Blockchain 0
No items for this category on selected date.
Breakthrough 0
No items for this category on selected date.
BuyBack 0
No items for this category on selected date.
Cancellations 0
No items for this category on selected date.
CashOffer 0
No items for this category on selected date.
Collaborate 0
No items for this category on selected date.
ContractWin 0
No items for this category on selected date.
Covid-19 0
No items for this category on selected date.
Deals 0
No items for this category on selected date.
Diamond 0
No items for this category on selected date.
DirectorDealing 0
No items for this category on selected date.
Discovery 0
No items for this category on selected date.
Exceeded 0
No items for this category on selected date.
FCA 0
No items for this category on selected date.
FDA 0
No items for this category on selected date.
Grants 0
No items for this category on selected date.
InvestmentPlan 0
No items for this category on selected date.
JV 0
No items for this category on selected date.
Launch 0
No items for this category on selected date.
Litigation 0
No items for this category on selected date.
NewContract 0
No items for this category on selected date.
Offers 0
No items for this category on selected date.
Offtake 0
No items for this category on selected date.
Orders 0
No items for this category on selected date.
Partner 0
No items for this category on selected date.
Patents 0
No items for this category on selected date.
Placing 0
No items for this category on selected date.
Positive 0
No items for this category on selected date.
Proposals 0
No items for this category on selected date.
Reports 1
HCM 08:31
HUTCHMED China Ltd
2025 Annual Report and Notice of AGM
Results 0
No items for this category on selected date.
Significant 0
No items for this category on selected date.
Speculation 0
No items for this category on selected date.
Strategic 0
No items for this category on selected date.
Suspension 0
No items for this category on selected date.
TR1 0
No items for this category on selected date.
Takeover 0
No items for this category on selected date.
Understanding 0
No items for this category on selected date.
Updates 0
No items for this category on selected date.
Vaccine 0
No items for this category on selected date.
Wins 0
No items for this category on selected date.
Worth 0
No items for this category on selected date.
All Market News (Last 30 Days) 4
HCM 08:31
HUTCHMED China Ltd
2025 Annual Report and Notice of AGM
HCM 06:01
HUTCHMED China Ltd
Data to be Presented at AACR Annual Meeting 2026
HCM 06:01
HUTCHMED China Ltd
HUTCHMED Initiates Phase III Trial of HMPL-760
HCM 07:31
HUTCHMED China Ltd
Vesting of awards under Long Term Incentive Plan
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
**Summary**
HUTCHMED (China) Limited announced the vesting of non-performance-based awards under its Long Term Incentive Plan (LTIP) on March 13, 2026. Dr. Weiguo Su, the companys Executive Director, Chief Executive Officer, and Chief Scientific Officer, received 19,913 ordinary shares as part of this vesting. The awards were initially granted on March 13, 2024. This notification complies with the UK Market Abuse Regulation and includes details about the transaction, the issuer, and the person discharging managerial responsibilities.
HUTCHMED is an innovative biopharmaceutical company focused on developing and commercializing targeted therapies and immunotherapies for cancer and immunological diseases. The company has successfully brought three medicines to market in China, with one also approved globally in regions including the US, Europe, and Japan. Contact information for investor and media enquiries, as well as details about the companys brokers, is provided. The announcement was released via RNS, the news service of the London Stock Exchange, on March 16, 2026.

AI Crunch

Single-Ticker AI Crunch
HCM signal theatre built from scored market catalysts, automated AI forecasts, and live trigger logic.

This is the ticker-specific AI Crunch desk for HUTCHMED China Ltd. It compresses bullish and bearish catalyst scoring, best and worst AI forecast paths, and automated buy or sell trigger logic into one cockpit so users can judge conviction without hopping across screens.

Subscription Required Bullish vs Bearish Scoring AI Forecast Stack Buy / Sell Trigger Engine Catalyst Ledger
Create Account Member Login
Subscriber Unlock
Subscribe to unlock the full HCM AI Crunch cockpit.

Subscription turns this tab into a live signal desk with bullish vs bearish machine scoring, AI forecast stack comparisons, buy and sell trigger logic, and the full catalyst ledger behind every scored catalyst row.

  • AI-scored market headlines with sentiment buckets and buzzword breakdowns.
  • Forecast leaders ranked by projected gain against current market price.
  • Advanced technical scans, AI forecast stacks, and predictive MACD inside the live stock terminal charts.
  • Single-ticker AI Crunch desks with buy or sell trigger logic and full catalyst ledgers.
  • Scored earnings shock board with predicted direction, sector pulse and catalyst narrative.
  • Fast market scan built for event-driven trading, not passive dashboards.
Subscribe to unlock the ticker-specific signal stack, sentiment gauges, forecast stage, and the full catalyst ledger for HCM on 2026-04-15.

Fundamentals Matrix

Overall Fundamentals
Signal: Pending
Capital Strength
Signal: Pending
Float Liquidity
Signal: Pending
Short Pressure
Signal: Pending
Target Setup
Signal: Pending
Market Profile
Signal: Pending
Market Cap
1908632448
Enterprise Value
896553209
Public Float
59.16
Broker Target
364.0557
Shares Out
859744319
Long Interest
-
Short Interest
-
Exchange
LSE
Currency Code
GBX
ISIN
KYG4672N1198
Market
LSE - AIM
Sector
Pharmaceuticals and Biotechnology
Float / Shares Ratio
-
Short vs Long Delta
-
EV / Market Cap
-

Financials Matrix

Overall Stability
Signal: Pending
Profitability
Signal: Pending
Debt & Cash
Signal: Pending
Valuation Risk
Signal: Pending
Forward Expectation
Signal: Pending
Dividend Safety
Signal: Pending
Divi Rate
-
Ex Divi
2009-01-01
Earnings Date
2026-03-23
Net Debt
26526779.0
Cash
71232732.0
EPS
0.4
Net Income
457021070.0
Revenue
548646538.0
Enterprise Value
896553209
Trailing PE
5.55
Forward PE
19.1939
Price Sales TTM
3.4797
Price Book MRQ
2.0278
EV Revenue
2.2623
EV EBITDA
2.4102

Capital Radar

Capital Regime
—
Building signal blend...
Smart Money Tilt
—
Public vs institutions
Target Conviction
—
Broker coverage pulse
Insider Pressure
—
Director + TR1 flow
Last Held Position
859744319
Public Hands
59.16
Institutions
-
Institutions As Of
-
Avg Broker Target
-
Upside Vs Price
-
Purchase Director Dealing
0
Sale Director Dealing
0
Purchase TR1
0
Sale TR1
0
Broker Coverage Rows
0
Institution Holders Tracked
0
Public Vs Institutional Ownership (3D)
Top Institution Holders (Latest Per Holder)
Director Dealing Sentiment Flow
Broker Target Bias
Signal: Pending
Capital Momentum Matrix
Broker Targets Vs Price
Aggregated Institution Weight By Holder

Short Data - Last 30 Days

Nexus Pulse Engine

Overall Buy/Sell/Hold
Signal: Pending
Technical Composite
Signal: Pending
Financial Composite
Signal: Pending
Fundamental Composite
Signal: Pending
Short Pressure
Signal: Pending
Momentum Bias
Signal: Pending

Volatility Lab

ATR(14)
Realized Vol (20d)
Volume Spike Z

AI Charts

Today's Catalysts

AI Charts is armed for the next catalyst in HCM.

No same-day headline has printed on 2026-04-15 yet, but the latest digestion is ready below the chart workflow and the catalyst beacons can still map the recent tape.
Standby Tape Data 2026-04-15 AI Charts Landing View
Scroll the tab rail to Digested News any time, or use the jump button to land straight on today's tape.
0 Today
Catalyst Pulse
Waiting for a fresh same-day headline while recent digestion stays on deck.
08:31 Latest Tape 2025 Annual Report and Notice of AGM 06:01 Latest Tape Data to be Presented at AACR Annual Meeting 2026 06:01 Latest Tape HUTCHMED Initiates Phase III Trial of HMPL-760
AI Charts Studio
HCM Price History
Live structure, automated forecasts, technical overlays and catalyst beacons in one chart workspace.
30 Day View Window 30D Data 2026-04-15 Open Preview Studio Brief
Chart Intelligence Suite
Swipe the timeframe, call the overlays, and keep the AI signal stack fused into one chart cockpit.
The mobile chart console is now framed as one connected surface so forecasting, structure, catalyst beacons and chart tools all sit inside the price workspace.

Automated signalling scans momentum shifts, crossovers and volatility breaks in real time. Automated AI forecasts map best, average and worst simulation paths forward, predictive MACD extends the momentum story, and catalyst beacons pin market-moving headlines directly onto price action so users can connect news, signals and structure without leaving the chart.

Automated Signalling Automated AI Forecasts Predictive MACD Catalyst Beacons Live Price Structure
TradingFloor AI Member Login
Indicators0
Technicals0
AI Forecast 1.63%
RSI Gauge
Price Change
AI Forecast